Search - tctmd.com

Displaying 41 - 56 of 56

Sort: Relevancy | Date

News Features

Grumbling Over Bundling: Cardiologists React Warily to Plans for Lump-Sum Payments for Cardiac Care

Caitlin E. Cox

September 23, 2016

News Features

The Bioresorbable Stent Story So Far: What Promise? What Price?

Michael O'Riordan

August 17, 2016

News Features

Requiem for a Heavyweight: Big Brand Statin Era Comes to a Close as Crestor Heads Off-Patent

Michael O'Riordan

May 03, 2016

News Features

The Heart Team: What Works, What Doesn’t, and What the Future Holds

Yael L. Maxwell

May 03, 2016

News Features

Asymptomatic Aortic Stenosis: The Next Frontier for TAVR?

L.A. McKeown

April 18, 2016

News Features

Hopes and Hype Await New Coronary Revascularization Appropriate Use Criteria in 2016

Caitlin E. Cox

March 21, 2016

News Features

Future of Renal Denervation May Hinge on a Handful of Small Studies

Todd Neale

February 14, 2016

News Features

Increased Early Risk of Stent Thrombosis With the Absorb Bioresorbable Scaffold

Michael O'Riordan

January 06, 2016

News Features

From Great to Greater: Innovation in Stent Technology Possible, Worth Pursuing

Todd Neale

November 08, 2015

News Features

Opportunities Exist for Hospitals, Interventionalists to Stave Off Unnecessary Readmissions

July 28, 2015

News Features

CMS Penalties Spur Efforts to Reduce 30-Day Hospital Readmissions

July 21, 2015

News Features

Drug-Coated Balloon Approvals Mark ‘Sea Change’ for Treatment of PAD

L.A. McKeown

January 28, 2015

News Features TCT 2014

Thoughtful Insights at TCT: Many Questions Remain Around Treatment of Valvular Disease

Todd Neale

October 24, 2014

News Features

Advocacy Group Blasts Mobile Cardiovascular Screening Company for ‘Unethical’ Practices

Yael L. Maxwell

June 27, 2014

News Features

Renal Denervation 2.0: Assessing the Failure of a Pivotal Trial

June 18, 2014

News Features

Shift in CMS Policy Shines Spotlight on PCI Readmissions

Yael L. Maxwell

July 09, 2012

Advertisement

Grumbling Over Bundling: Cardiologists React Warily to Plans for Lump-Sum Payments for Cardiac Care

The Bioresorbable Stent Story So Far: What Promise? What Price?

Requiem for a Heavyweight: Big Brand Statin Era Comes to a Close as Crestor Heads Off-Patent

The Heart Team: What Works, What Doesn’t, and What the Future Holds

Asymptomatic Aortic Stenosis: The Next Frontier for TAVR?

Hopes and Hype Await New Coronary Revascularization Appropriate Use Criteria in 2016

Future of Renal Denervation May Hinge on a Handful of Small Studies

Increased Early Risk of Stent Thrombosis With the Absorb Bioresorbable Scaffold

From Great to Greater: Innovation in Stent Technology Possible, Worth Pursuing

Opportunities Exist for Hospitals, Interventionalists to Stave Off Unnecessary Readmissions

CMS Penalties Spur Efforts to Reduce 30-Day Hospital Readmissions

Drug-Coated Balloon Approvals Mark ‘Sea Change’ for Treatment of PAD

Thoughtful Insights at TCT: Many Questions Remain Around Treatment of Valvular Disease

Advocacy Group Blasts Mobile Cardiovascular Screening Company for ‘Unethical’ Practices

Renal Denervation 2.0: Assessing the Failure of a Pivotal Trial

Shift in CMS Policy Shines Spotlight on PCI Readmissions

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content